Mezzion Decides to Issue Convertible Bonds with Put/Call Options
- Decision to issue convertible bonds (detailed terms such as issuance size and conversion price not disclosed)
- Issuance targets: multiple private equity funds including Tiger Asset Management, Anda Asset Management, NH Hedge Asset Management, and GVA Asset Management
- Put option (early redemption right): exercisable every 3 months from 24 months (May 12, 2028) to 57 months (Feb 12, 2031) after issuance, early redemption yield of 2% compounded annually
- Call option: exercisable by the issuer every 3 months from 12 months (May 12, 2027) to 24 months (May 12, 2028) after issuance, yield of 3% compounded annually, limited to 20% of each underwriter's initial issuance amount
- Underwriters must hold 20% of bonds (call option subject bonds) without conversion until the end of the call option period
- Put option has priority over call option; mandatory holding obligation is void upon exercise of put option
- Uncertain dilution effect and funding purpose due to undisclosed conversion price and other terms
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Report On Major Events (Decision On Issuance Of Convertible Bonds)
- Company: Mezzion Pharma (140410)
- Submission: Mezzion Pharma Co., Ltd.
- Receipt: 04-30-2026